A timely diagnosis and discontinuation of antipsychotic therapy stand as first-line treatment for neuroleptic malignant syndrome (NMS), followed by supportive care and pharmacotherapy, a review ...

Providing the latest peer-reviewed research on the clinical and biological aspects of treating this patient population with psychotropic medications, including side effects and interactions, standard ...

NMS patients (n = 13) Cases 1–5 "rapid dose escalators" (n = 5) Cases 6–13 "non rapid dose escalators" (n = 8) Clozapine titration Mean cumulative total antipsychotic dose (mg) Days 1–15 3625.1 512.4 ...

A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic ...

"Neuroleptic malignant syndrome" (NMS) derives from the French "syndrome malin des neuroleptiques" and was first described in 1960 by Delay [1] and colleagues in association with haloperidol. It is a ...